We saw the fate of fluorescent α-galactosylceramide (Cy5-αGC) in vivo and in vitro.
CD8+ dendritic cells (DCs) captured more αGC than CD8− DCs in vivo and in vitro.
Cy5-αGC was more stable in CD8+ DCs than in CD8− DCs.
Langerin+CD8+ DCs in the splenic marginal zone incorporated Cy5-αGC.
Splenic CD8+ DCs expressed more CXCL16, which might anchor iNKT cells, than CD8− DCs.